{
    "clinical_study": {
        "@rank": "136445", 
        "brief_summary": {
            "textblock": "To compare the safety and efficacy profiles of decitabine to those of supportive care in\n      adults with advanced-stage myelodysplastic syndrome (MDS)"
        }, 
        "brief_title": "Decitabine Versus Supportive Care in Adults With Advanced-stage MDS", 
        "completion_date": {
            "#text": "April 2003", 
            "@type": "Actual"
        }, 
        "condition": "Myelodysplastic Syndrome", 
        "condition_browse": {
            "mesh_term": [
                "Myelodysplastic Syndromes", 
                "Preleukemia"
            ]
        }, 
        "detailed_description": {
            "textblock": "This experimental (investigational) study is intended to answer the question of whether\n      decitabine is any better than supportive care alone in delaying progression (worsening) of\n      the disease, prolonging survival or improving the overall quality of life for MDS patients\n      who are not candidates for bone marrow transplant (BMT)."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion:\n\n          -  MDS (de novo or secondary) fitting any of the recognized French-American-British,\n             FAB, classifications or chronic myelomonocytic leukemia (CMML) with WBC < 12,000/mm3,\n             AND International Prognostic Scoring System (IPSS) >/= 0.5 as determined by CBC, bone\n             marrow assessment and bone marrow cytogenetics within 30 days of randomization\n\n          -  18 years or older\n\n          -  Female patients of child-bearing potential must have a negative serum hCG within 24\n             hours prior to randomization, must practice a medically approved method of birth\n             control for the past 30 days, and agree to continue this practice for the trial\n             duration and must not be breast-feeding\n\n          -  ECOG or WHO performance status of 0-2\n\n          -  Written informed consent\n\n          -  Normal renal and hepatic function (creatinine </= 2 mg/dL, bilirubin </= 1.5 mg/dL,\n             SGPT </= 2 times the upper limit of normal range)\n\n        Exclusion:\n\n          -  Acute Myeloid Leukemia (AML) (>/=30% bone marrow blasts) or other progressive\n             malignant disease\n\n          -  Patients must have recovered from the toxic effects of prior therapy and must be off\n             all chemotherapy for a minimum of 4 weeks prior to study entry to the protocol (a\n             minimum of six weeks for prior nitrosoureas and bone marrow transplantation)\n\n          -  Ongoing treatment with androgenic hormones, danazol, colony-stimulating factors, or\n             other agents used to treat MDS within 7 days of study initiation.\n\n          -  Administration of any investigational agent within the 30 days preceding study\n             initiation.\n\n          -  Uncontrolled cardiac disease or congestive heart failure\n\n          -  Uncontrolled restrictive or obstructive pulmonary disease\n\n          -  Active viral or bacterial infection\n\n          -  Superimposed autoimmune hemolytic anemia or thrombocytopenia\n\n          -  Known positive serology for HIV\n\n          -  Mental illness or other condition preventing full cooperation with the treatment and\n             monitoring requirements of the study."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": "160", 
        "firstreceived_date": "August 8, 2002", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_alias": "NCT00022061", 
            "nct_id": "NCT00043381", 
            "org_study_id": "D-0007"
        }, 
        "intervention": {
            "intervention_name": "decitabine (5-aza-2'deoxycytidine)", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Azacitidine", 
                "Decitabine"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": [
            "myelodysplastic syndrome", 
            "MDS", 
            "chronic myelomonocytic leukemia", 
            "CMML", 
            "decitabine", 
            "5-aza-2'deoxycytidine"
        ], 
        "lastchanged_date": "January 22, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Berkeley", 
                        "country": "United States", 
                        "state": "California"
                    }, 
                    "name": "Alta Bates Comprehensive Cancer Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Duarte", 
                        "country": "United States", 
                        "state": "California"
                    }, 
                    "name": "City of Hope National Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Escondido", 
                        "country": "United States", 
                        "state": "California"
                    }, 
                    "name": "Scripps Clinic"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Loma Linda", 
                        "country": "United States", 
                        "state": "California"
                    }, 
                    "name": "Loma Linda Univ. Cancer Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Francisco", 
                        "country": "United States", 
                        "state": "California"
                    }, 
                    "name": "Univ. California San Francisco Medical School"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Gainsville", 
                        "country": "United States", 
                        "state": "Florida"
                    }, 
                    "name": "University of Florida"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tampa", 
                        "country": "United States", 
                        "state": "Florida"
                    }, 
                    "name": "James A. Haley Veteran's Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tampa", 
                        "country": "United States", 
                        "state": "Florida"
                    }, 
                    "name": "H. Lee Moffitt Cancer Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois"
                    }, 
                    "name": "University of Illinois at Chicago"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois"
                    }, 
                    "name": "Rush Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts"
                    }, 
                    "name": "Dana Farber Cancer Institute"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts"
                    }, 
                    "name": "New England Medical Center Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Worcester", 
                        "country": "United States", 
                        "state": "Massachusetts"
                    }, 
                    "name": "University of Massachusetts Medical School"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Minneapolis", 
                        "country": "United States", 
                        "state": "Minnesota"
                    }, 
                    "name": "VA Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "St. Louis", 
                        "country": "United States", 
                        "state": "Missouri"
                    }, 
                    "name": "Washington Univ. School of Medicine"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Buffalo", 
                        "country": "United States", 
                        "state": "New York"
                    }, 
                    "name": "Roswell Park Cancer Institute"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York"
                    }, 
                    "name": "Memorial Sloan Kettering Cancer Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York"
                    }, 
                    "name": "Mount Sinai Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chapel Hill", 
                        "country": "United States", 
                        "state": "North Carolina"
                    }, 
                    "name": "UNC Lineberger Comprehensive Cancer Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Durham", 
                        "country": "United States", 
                        "state": "North Carolina"
                    }, 
                    "name": "Duke University Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Memphis", 
                        "country": "United States", 
                        "state": "Tennessee"
                    }, 
                    "name": "The Memphis Cancer Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Austin", 
                        "country": "United States", 
                        "state": "Texas"
                    }, 
                    "name": "SW Regional Cancer Center (dba Central Texas Oncology Associates)"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dallas", 
                        "country": "United States", 
                        "state": "Texas"
                    }, 
                    "name": "Texas Oncology"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas"
                    }, 
                    "name": "MD Anderson Cancer Center"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "A Randomized, Open-label, Phase III Trial of Decitabine (5-aza-2'Deoxycytidine) Versus Supportive Care in Adults With Advanced-stage Myelodysplastic Syndrome", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "November 2002", 
            "@type": "Actual"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00043381"
        }, 
        "responsible_party": {
            "name_title": "David S. Smith, Vice President-Regulatory and Quality Assurance", 
            "organization": "SuperGen, Inc."
        }, 
        "source": "Astex Pharmaceuticals", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Astex Pharmaceuticals", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "April 2001", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2011"
    }, 
    "geocoordinates": {
        "Alta Bates Comprehensive Cancer Center": "37.872 -122.273", 
        "City of Hope National Medical Center": "34.139 -117.977", 
        "Dana Farber Cancer Institute": "42.358 -71.06", 
        "Duke University Medical Center": "35.994 -78.899", 
        "H. Lee Moffitt Cancer Center": "27.951 -82.457", 
        "James A. Haley Veteran's Hospital": "27.951 -82.457", 
        "Loma Linda Univ. Cancer Center": "34.048 -117.261", 
        "MD Anderson Cancer Center": "29.76 -95.369", 
        "Memorial Sloan Kettering Cancer Center": "40.714 -74.006", 
        "Mount Sinai Medical Center": "40.714 -74.006", 
        "New England Medical Center Hospital": "42.358 -71.06", 
        "Roswell Park Cancer Institute": "42.886 -78.878", 
        "Rush Medical Center": "41.878 -87.63", 
        "SW Regional Cancer Center (dba Central Texas Oncology Associates)": "30.267 -97.743", 
        "Scripps Clinic": "33.119 -117.086", 
        "Texas Oncology": "32.803 -96.77", 
        "The Memphis Cancer Center": "35.15 -90.049", 
        "UNC Lineberger Comprehensive Cancer Center": "35.913 -79.056", 
        "Univ. California San Francisco Medical School": "37.775 -122.419", 
        "University of Florida": "29.652 -82.325", 
        "University of Illinois at Chicago": "41.878 -87.63", 
        "University of Massachusetts Medical School": "42.263 -71.802", 
        "VA Medical Center": "44.98 -93.264", 
        "Washington Univ. School of Medicine": "38.627 -90.199"
    }
}